Condition: Aortic Dissection · Sponsor: Ottawa Heart Institute Research Corporation
HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.
This description comes directly from the study's public registry record.
Khatira Mehdiyeva · 613-696-7000 · kmehdiyeva@ottawaheart.ca
Alice Black · 403-389-8958 · AlBlack@ottawaheart.ca
Always discuss trial participation with your own doctor first.
| London Health Sciences Centre | London, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| Montreal Heart Institute | Montreal, Quebec, Canada | Recruiting |
| Institut Universitaire De Cardiologie Et De Pneumologie de Québec | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03885635